Lu177PSMA617 (Pluvicto) FDA-approved ... - Advanced Prostate...

Advanced Prostate Cancer

22,370 members28,134 posts

Lu177PSMA617 (Pluvicto) FDA-approved today

Tall_Allen profile image
70 Replies

It was approved only for for patients who are metastatic and have been previously treated with androgen receptor (AR) pathway inhibition (e.g., Zytiga,Xtandi,or Erleada) and taxane-based chemotherapy. They also approved Ga68PSMA11 PET (Locametz) for identification of PSMA-avid patients (it was formerly approved for high risk and recurrent patients).

Novartis expects it will be widely distributed in weeks.

globenewswire.com/news-rele...

Edit: Here's the prescribing information and potential adverse reactions:

accessdata.fda.gov/drugsatf...

Written by
Tall_Allen profile image
Tall_Allen
To view profiles and participate in discussions please or .
Read more about...
70 Replies
leebeth profile image
leebeth

Great news!

Happle58 profile image
Happle58

Awesome! Thank you!!

MateoBeach profile image
MateoBeach

Wow! Wonderful and long awaited announcement.

Longterm101 profile image
Longterm101

hoping for another silver bullet to come out soon. Anything on the horizon???

Tall_Allen profile image
Tall_Allen in reply toLongterm101

For newly diagnosed: combo of docetaxel and AR pathway inhibition. Many trials are genomically tailored.

GeorgeGlass profile image
GeorgeGlass in reply toTall_Allen

Following the successful results of the ARASENS study, how long do you think it will be before the FDA approves Darolutimide for castration sensitive men?

Are there any planned studies to compare: ADT + ARI vs ADT + Docetaxal + ARI?

ARASENS should have added a third group of men with Darolutimide + ADT but no docetaxal to see if docetaxel added significant amounts to OS, especially since many of the men starting on Darolutimide have already been on ADT for several years (not recently diagnosed with cancer).

teacherdude70 profile image
teacherdude70 in reply toGeorgeGlass

How long has Darolutimide been in use?

Oldie68 profile image
Oldie68 in reply toteacherdude70

FDA approved since July 2019.

GeorgeGlass profile image
GeorgeGlass in reply toteacherdude70

a few years - clinical studies go back further

treedown profile image
treedown

Hoping its a long time before I meet that criteria.

GeorgeGlass profile image
GeorgeGlass in reply totreedown

It should be approved for castration sensitive and metastatic within the next year or two I estimate.

dublin1717 profile image
dublin1717

Thanks TA.

Rondief profile image
Rondief

Woot woot! I’ve been waiting for this. Thanks for the update TA

Mount_Rainier profile image
Mount_Rainier

Thanks TA!! I’m here getting a Chemo treatment and just found out my PSA is-over 1000! Great news!

Gudgelm profile image
Gudgelm

T-A Are there any studies aimed at hormone sensitive patients. Any prognostications on when radioligands might be approved for oligometatastic patients?

Tall_Allen profile image
Tall_Allen in reply toGudgelm

Just for newly diagnosed mHSPC.

spencoid2 profile image
spencoid2 in reply toTall_Allen

Are you referring to the one study for mHSPC? this is not approved for mHSPC, right?

Tall_Allen profile image
Tall_Allen in reply tospencoid2

Gudgelm asked about the trial for mHSPC - it is for newly diagnosed men.

TJGuy profile image
TJGuy in reply toTall_Allen

Tall-Allen

Please explain what is ment by metastic? Does that mean bones only? Lymph nodes, where do they have to be, outside pelvic area? Organs?

Please explain more clearly what you mean by newly diagnosed, while still referring to having had chemo and AR. AR being resistant to androgen receptor directed 2nd line ADT ?

Please help me/us understand it. Is this correct?

Androgen naive - never had ADT

Androgen sensitive - aka hormone sensitive, ADT still effective

Hormone resistant. 1st line ADT not working, 2nd line ADT effective.

Castrate resistant All ADT not effective

Or are hormone resistant and castrate resistant the same?

On another question

What does it mean to be stage 4 as opposed to stage 3.

What and Where does your cancer have to be to be stage 4?

Does failing RP and whole pelvic salvage radiation make you stage 4?

Tall_Allen profile image
Tall_Allen in reply toTJGuy

Metastases are cancers outside the place of origin. For prostate cancer, that usually means lymph nodes (Called N1 if pelvic, called M1a if beyond the pelvic area) or bones (called M1b), and sometimes distant visceral organs like the liver or lungs (called M1c).

Newly diagnosed means treatment-naive. If you've had chemo or advanced hormone therapy, you are not newly diagnosed.

Castration resistant means that the cancer progresses in spite of ADT. "Hormone resistant" is not used.

Stage IV means the cancer is outside of the prostate, either in adjoining organs (T4) or metastasized.

Failing salvage therapy is designated as "recurrent"(stage R1) or "persistent." Stage IV is only designated if found on biopsy, CT or MRI.

TJGuy profile image
TJGuy in reply toTall_Allen

Thanks if I can drill a little further if you don't mind.

So where you say advanced hormone therapy, your referring to 1st level such as Lupron and 2nd level such as Zytiga, meaning either level constitutes advanced hormone therapy?

You could have been n0m0 at RP, with with persistent PSA or recurrent rising PSA, but then of course become n1 and/or m1 later on by findings on a scan(s) etc. Either n1 (local) or m1 (distant) means your metastatic.

Are you saying that PSMA, AXUMIN, or Choline scans as they employ a CT scan as part of the PET scan, could also be used to determine existence of PC.

And rising PSA alone(( three consecutive blood tests at 3 month intervals) (either above 0.1 or below 0.1 )) after RP or whole pelvic Salvage Radiation cannot be used to classify as Stage4. Even if scans prior to RP or prior to Salvage radiation showed PC mets.

It must be located and confirmed by scan, MRI, or biopsy after Salvage Radiation.

That's a lot of drilling but think it really clarifies it.

Thanks

Tall_Allen profile image
Tall_Allen in reply toTJGuy

"So where you say advanced hormone therapy, your referring to 1st level such as Lupron and 2nd level such as Zytiga, meaning either level constitutes advanced hormone therapy?" No. Lupron is ADT, not advanced hormone therapy.

"Are you saying that PSMA, AXUMIN, or Choline scans as they employ a CT scan as part of the PET scan, could also be used to determine existence of PC?"

PET scans are not currently used to formally determine N1 or M1 (according to AJCC), only CT, MRI or biopsy, as I wrote. But the formal AJCC stages are not used in practice. All oncologists use PET scans if they are available.

Nite-owl profile image
Nite-owl

Any use on metastatic hormone sensitive PC other than trials?

Tall_Allen profile image
Tall_Allen in reply toNite-owl

Not in the US.

Schwah profile image
Schwah in reply toTall_Allen

Anywhere in the US allow a HSPC patient to do the LU77 out of pocket? If so any idea what that might cost? What are your thoughts on efficacy for HSPC TA?

Schwah

Tall_Allen profile image
Tall_Allen in reply toSchwah

No idea what it would cost out of pocket. But it is available off-label now. I would guess it's useful and not too toxic as long as there are enough mets of sufficient PSMA-avidity.

Yadifan profile image
Yadifan

Thank TA! Great news!

garyjp9 profile image
garyjp9

Thank you very much, TA

Wings-of-Eagles profile image
Wings-of-Eagles

Good news , thanks much for for the info, as always...have not read the clickable link yet, but in brief what is are Taxane based chemotherapy? Is that docetaxel,or something else?

Wings

BTW, I am still on Zytiga and still PSA undetectable, 7 years ,4 months now

Tall_Allen profile image
Tall_Allen in reply toWings-of-Eagles

I hope you continue to set records for Zytiga use. Taxane means either docetaxel (Taxotere) or cabazitaxel Jevtana).

TNCanuck profile image
TNCanuck in reply toWings-of-Eagles

Fantastic! My husband's PSA remains undetectable at five years this month. He's on Lupron only after a very early cycle of Docetaxel and a very short stint on Zytiga in early 2018.

Muffin2019 profile image
Muffin2019 in reply toWings-of-Eagles

How can you go that long with zgetia without the osa going up ?

Scout4answers profile image
Scout4answers in reply toWings-of-Eagles

Did you take Lupron? have surgery or radiation?

rosatt1 profile image
rosatt1

Thanks for the important information.

CAMPSOUPS profile image
CAMPSOUPS

Worthy of a toast to all who came before us. Around the world. In trials.Thanks for letting us all know right away.

tallguy2 profile image
tallguy2

Thanks for posting this, Allen. Another tool in the toolkit.Question: does the Lu-177 only target prostate cancer cells expressing PSMA? The reason I ask is that I erroneously thought the tumor in my bladder was bladder cancer. My oncologist told me today that it's prostate cancer that doesn't express PSMA.

Tall_Allen profile image
Tall_Allen in reply totallguy2

Yes, Pluvicto only kills metastatic PCa that expresses PSMA. PCa that has eaten its way up to the bladder (Stage T4) is not metastatic and may be killed by a combination of targeted radiation and hormone therapy.

Concerned-wife profile image
Concerned-wife in reply toTall_Allen

Now you’ve given me something else to learn. I would have assumed this would have been metastatic

tallguy2 profile image
tallguy2 in reply toTall_Allen

I cannot have a curative dose to my bladder as I had salvage radiation treatment in 2012.I learned yesterday that my cancer has progressed into my liver and lungs. I am being considered for yet another trial and if not then it’s the nasty chemo combo for me.

GeorgeGlass profile image
GeorgeGlass

Good to hear. I'll remove the question of my doc whether I can get LU-177 before an AR like one guy successfully did. He went to another country for the treatment.

My concern with LU-177 is what happened to Great John. John told me that his reaction to the 177 (which killed him), occurs in 10% of LU-177 patients. Do you think LU-177 is more risky than docetaxal?

Tall_Allen profile image
Tall_Allen in reply toGeorgeGlass

See:

prostatecancer.news/2019/12...

longleaf profile image
longleaf in reply toTall_Allen

Thank you for this link and the comprehensive summary.

GeorgeGlass profile image
GeorgeGlass in reply toTall_Allen

Informative and complex analysis. Sounds like a third line treatment option for select patients, based on their scan results.

Jawbreaker profile image
Jawbreaker

Great News , fantastic

Jawbreaker profile image
Jawbreaker

Thank you for the great news

Jawbreaker profile image
Jawbreaker

Great news!!

PSA680 profile image
PSA680

Thank you - I hope it gets approved in the UK soon & trials are made into widening the scope of approval ie earlier in treatment lifecycle.

Tall_Allen profile image
Tall_Allen in reply toPSA680

NICE finally recommended Xofigo, so I'm hopeful they will.

MMK-XFuture profile image
MMK-XFuture

Thanks for the update, TA. You rock!

tayninhtom profile image
tayninhtom

Thanks for the update. A month ago I spoke to Dr. Okunieff at Shands in Gainesville Florida. He mentioned they were using it for high risk patients only. It sounds like we are finally catching up with European countries.

Tall_Allen profile image
Tall_Allen in reply totayninhtom

US laws restricts new drugs to FDA approval. In Germany, they allow doctors to use experimental drugs for patients who have a terminal illness that cannot be treated satisfactorily with an authorized medicinal product (Compassionate Use Law). Because of FDA authorization, the European Medicines Agency can now approve Pluvicto for widespread use throughout Europe as is now allowed in the US. FDA authorization is rigorous and is accepted by all countries. Some countries have another layer of authorization based on cost-benefit analysis.

larry_dammit profile image
larry_dammit

Great news, it sounds like we can buy a few more months with this treatment 😀😀

Fightinghard profile image
Fightinghard

Thanks TA for sharing the great news. Hoping this added weapon helps many of us. Any guess on how long it might take medicare to begin coverage?

Tall_Allen profile image
Tall_Allen in reply toFightinghard

Usually takes a few months. I think Medicare makes reimbursement possible to the date of FDA approval, but I expect it will cost a lot.

dockam profile image
dockam in reply toTall_Allen

Patients will be capped at six doses administered six weeks apart, leading to a potential maximum cost per patient of $255,000, the spokesperson added. endpts.com/novartis-radioph...

Fightinghard profile image
Fightinghard in reply todockam

Thank you TA. I just finished Provenge this week so I should have a few months before next meds at least (I hope)

Tall_Allen profile image
Tall_Allen in reply toFightinghard

I encourage you to look into radiation (Xofigo or Pluvicto) very soon after Provenge. There is evidence of synergy.

Fightinghard profile image
Fightinghard in reply toTall_Allen

Will discuss with my MO next month. Thx

My husband is in line - It will be intersting to see how long it will take to get an acutal appointment/insurance blah blah... A little leary of going to Ohio State because it's super new to them. OSU just took over the Dayton Physicians Practice that has been working with in the clinical trials with LU177. Curious if LU177 had anything to do with the buy out of Dayton Physicians Practice.

Tall_Allen profile image
Tall_Allen in reply toNotAlwaysSunshine

Administering Pluvicto shouldn't be too difficult. I'm worried more about the learning curve for reading the Locametz PET scans by radiologists.

NotAlwaysSunshine profile image
NotAlwaysSunshine in reply toTall_Allen

EXACTLY! The learning curve. OSU said they hired a physician to read the Locametz PET. I'll be asking questions to see how many he has read.

leo2634 profile image
leo2634

Thank you T_A for always keeping us posted.

db1966 profile image
db1966

Thank you for this info. You really have to go into this with eyes wide open with the side effects.

Karirudy profile image
Karirudy

My husband just finished 6 rounds of docetoxel in January. We had one of two scans this week. Psa jumped from 4 to 23. MO says LU-177 wont be available till December. She has referred us to a Dr. Wang for possible clinical trials.... our house is almost done in Mexico. We thought we were just coming for scans and Eligard. MO cancelled CT scan and ordered PMSA scan.

House picture
Gabby643 profile image
Gabby643

Thanks TA

slpdvmmd profile image
slpdvmmd

Info on base proposed pricing. endpts.com/novartis-radioph...

j-o-h-n profile image
j-o-h-n

Geez thanks T_A...... the news gave me an erection (short lived however)....

Good Luck, Good Health and Good Humor.

j-o-h-n Thursday 03/24/2022 3:48 PM DST

mrscruffy profile image
mrscruffy

I have a question. Is LU-177 a series of treatments? One and done? Or yearly thing?

Tall_Allen profile image
Tall_Allen in reply tomrscruffy

They approved up to 6 treatments.

Shams_Vjean profile image
Shams_Vjean

Thanks, TA!

Not what you're looking for?

You may also like...

Update: FDA grants Priority Review for 177Lu-PSMA-617 for patients with metastatic castration-resistant

FDA grants Priority Review for investigational targeted radioligand therapy 177Lu-PSMA-617 for...
GregHouston profile image

FDA Approves Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer

Other triple therapy approved by the FDA. The article has the basic results of the ARASENS trial....
tango65 profile image

Xtandi (enzalutamide) +ADT slows metastases in recurrent men

We recently saw that ADT+Erleada (apalutamide) slows progression compared to ADT alone....
Tall_Allen profile image

Pluvicto supply increasing

Patients should be able to begin Pluvicto therapy within 2 weeks of qualifying for it....
Tall_Allen profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.